These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6271545)

  • 1. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications.
    Larsen PR; Silva JE; Kaplan MM
    Endocr Rev; 1981; 2(1):87-102. PubMed ID: 6271545
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.
    Larsen PR; Dick TE; Markovitz BP; Kaplan MM; Gard TG
    J Clin Invest; 1979 Jul; 64(1):117-28. PubMed ID: 447848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of drugs on peripheral thyroxine metabolism.
    Wartofsky L; Burman KD
    Horm Metab Res Suppl; 1984; 14():105-8. PubMed ID: 6096249
    [No Abstract]   [Full Text] [Related]  

  • 4. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release.
    Silva JE; Larsen PR
    J Clin Invest; 1978 May; 61(5):1247-59. PubMed ID: 207733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of thyroxine and triiodothyronine on the thyrotrophin response to thyrotrophin-releasing hormone in normal and iopanoic acid-treated euthyroid rats.
    Boado R; Ulloa E; Zaninovich AA
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):205-9. PubMed ID: 6814137
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of thyrotropin secretion by 3,5,3'-triiodothyronine and thyroxine.
    Larsen PR
    Prog Clin Biol Res; 1981; 74():81-93. PubMed ID: 6275408
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion of thyroxine to triiodothyronine in the anterior pituitary gland and the influence of this process on thyroid status.
    Kaplan MM; Breitbart R
    Horm Metab Res Suppl; 1984; 14():79-85. PubMed ID: 6595194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyrotropic hormone and the thyroid gland (present status)].
    Kalinin AP; Izmaĭlov GI
    Ter Arkh; 1977; 49(12):131-7. PubMed ID: 414369
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only.
    Lim VS; Passo C; Murata Y; Ferrari E; Nakamura H; Refetoff S
    Endocrinology; 1984 Jan; 114(1):280-6. PubMed ID: 6317348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of circulating thyroid hormones and local mechanisms in determining the concentration of T3 in various tissues.
    Silva JE
    Prog Clin Biol Res; 1983; 116():23-44. PubMed ID: 6304778
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclear thyroid hormone receptors.
    Wiersinga WM
    Neth J Med; 1985; 28(2):74-82. PubMed ID: 2983247
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors regulating triiodothyronine (T3) and thyroxine (T4) in blood.
    Greer MA
    Mayo Clin Proc; 1972 Dec; 47(12):944-52. PubMed ID: 4564709
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroxine, triiodothyronine, and thyrotropin in serum during long-term diphenylhydantoin therapy.
    Liewendahl K; Majuri H
    Scand J Clin Lab Invest; 1976 Mar; 36(2):141-4. PubMed ID: 179126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An essential role of thyroxine and triiodothyronine balance in establishing normal pituitary-thyroid feedback control in goitrogen-treated rats.
    Yamada T; Lewis AE
    Endocrinology; 1968 Jan; 82(1):91-9. PubMed ID: 4169407
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Iopanoic acid on the pituitary-thyroid axis: time sequence of changes in serum iodothyronines, thyrotropin, and prolactin concentrations and responses to thyroid hormones.
    Suzuki H; Noguchi K; Nakahata M; Nakagawa S; Kadena N
    J Clin Endocrinol Metab; 1981 Oct; 53(4):779-83. PubMed ID: 6793610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of thyrotropin secretion by thyroxine and triiodothyronine.
    Boado R; Ulloa E; Zaninovich AA
    Prog Clin Biol Res; 1983; 116():131-7. PubMed ID: 6407030
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid development and disorders of thyroid function in the newborn.
    Fisher DA; Klein AH
    N Engl J Med; 1981 Mar; 304(12):702-12. PubMed ID: 6258072
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of the secretion of thyroid stimulating hormone by endogenous triiodothyronine and thyroxine: an observation on a patient of chronic thyroiditis treated with corticosteroid.
    Sakurada T; Saito S; Yamamoto M; Yamaguchi T; Yoshida K
    Tohoku J Exp Med; 1974 Apr; 112(4):361-4. PubMed ID: 4854534
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of simultaneously administered iopanoic acid and thyrotropin releasing hormone (TRH) on thyroid hormone metabolism in euthyroid subjects.
    Szabolcs I; Kovács Z; Góth M; Szilágyi G
    Exp Clin Endocrinol; 1988 Aug; 91(3):365-8. PubMed ID: 3150834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyshormonogenetic goitre with high circulating levels of thyroid-stimulating hormone.
    Harvey RF; Doniach D
    Proc R Soc Med; 1971 Mar; 64(3):299-300. PubMed ID: 4101504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.